The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Flamengo defeated by PSG in Qatar tournament
- Flavors of Brazil on Egyptian screens
- UAE opens market to Brazil’s bovine embryos
- Jordanian company stands out in female employment
- Brazil’s franchising sector grows 9.1%
- Arabs compete in volleyball championship in Pará
- São Paulo mall offers immersion in Ancient Egypt
- Flamengo, PSG face off in tournament in Qatar
